{"id":49732,"date":"2022-10-18T12:02:11","date_gmt":"2022-10-18T10:02:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/adme-toxicology-testing-global-market-report-2022-increased-need-to-check-late-stage-drug-failures-drives-growth-researchandmarkets-com\/"},"modified":"2022-10-18T12:02:11","modified_gmt":"2022-10-18T10:02:11","slug":"adme-toxicology-testing-global-market-report-2022-increased-need-to-check-late-stage-drug-failures-drives-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/adme-toxicology-testing-global-market-report-2022-increased-need-to-check-late-stage-drug-failures-drives-growth-researchandmarkets-com\/","title":{"rendered":"ADME-Toxicology Testing Global Market Report 2022: Increased Need to Check Late-Stage Drug Failures Drives Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “ADME-Toxicology Testing – Global Market Trajectory & Analytics”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nGlobal ADME-Toxicology Testing Market to Reach $12.3 Billion by 2027<\/strong>\n<\/p>\n

\nIn the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$12.3 Billion by 2027, growing at a CAGR of 10.9% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 13.4% CAGR and reach US$5.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the High Throughput Screening segment is readjusted to a revised 7.6% CAGR for the next 7-year period.\n<\/p>\n

\nThe U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 15.4% CAGR<\/strong>\n<\/p>\n

\nThe ADME-Toxicology Testing market in the U.S. is estimated at US$3 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$966.9 Million by the year 2027 trailing a CAGR of 15.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 12.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR.\n<\/p>\n

\nMolecular Imaging Segment to Record 9.6% CAGR<\/strong>\n<\/p>\n

\nIn the global Molecular Imaging segment, USA, Canada, Japan, China and Europe will drive the 9.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$974.7 Million in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.\n<\/p>\n

\nSelect Competitors (Total 79 Featured) –<\/strong>\n<\/p>\n